Literature DB >> 25307283

The effect of sulforaphane on histone deacetylase activity in keratinocytes: Differences between in vitro and in vivo analyses.

Sally E Dickinson1,2, Jadrian J Rusche1, Sergiu L Bec1, David J Horn1, Jaroslav Janda1, So Hyun Rim1, Catharine L Smith3, G Timothy Bowden1,4.   

Abstract

Sulforaphane is a natural product found in broccoli, which is known to exert many different molecular effects in the cell, including inhibition of histone deacetylase (HDAC) enzymes. Here, we examine for the first time the potential for sulforaphane to inhibit HDACs in HaCaT keratinocytes and compare our results with those found using HCT116 colon cancer cells. Significant inhibition of HDAC activity in HCT116 nuclear extracts required prolonged exposure to sulforaphane in the presence of serum. Under the same conditions HaCaT nuclear extracts did not exhibit reduced HDAC activity with sulforaphane treatment. Both cell types displayed down-regulation of HDAC protein levels by sulforaphane treatment. Despite these reductions in HDAC family member protein levels, acetylation of marker proteins (acetylated Histone H3, H4, and tubulin) was decreased by sulforaphane treatment. Time-course analysis revealed that HDAC6, HDAC3, and acetylated histone H3 protein levels are significantly inhibited as early as 6 h into sulforaphane treatment. Transcript levels of HDAC6 are also suppressed after 48 h of treatment. These results suggest that HDAC activity noted in nuclear extracts is not always translated as expected to target protein acetylation patterns, despite dramatic inhibition of some HDAC protein levels. In addition, our data suggest that keratinocytes are at least partially resistant to the nuclear HDAC inhibitory effects of sulforaphane, which is exhibited in HCT116 and other cells.
© 2014 The Authors. Molecular Carcinogenesis published by Wiley Periodicals, Inc.

Entities:  

Keywords:  chemoprevention; isothiocyanate; skin

Mesh:

Substances:

Year:  2014        PMID: 25307283      PMCID: PMC4394046          DOI: 10.1002/mc.22224

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  34 in total

Review 1.  Roles and mechanisms of action of the Nrf2 transcription factor in skin morphogenesis, wound repair and skin cancer.

Authors:  T A Beyer; U Auf dem Keller; S Braun; M Schäfer; S Werner
Journal:  Cell Death Differ       Date:  2007-03-23       Impact factor: 15.828

Review 2.  New and emerging HDAC inhibitors for cancer treatment.

Authors:  Alison C West; Ricky W Johnstone
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

3.  Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs.

Authors:  Hyun-Jung Kim; Suk-Chul Bae
Journal:  Am J Transl Res       Date:  2010-12-26       Impact factor: 4.060

4.  Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice.

Authors:  Melinda C Myzak; W Mohaiza Dashwood; Gayle A Orner; Emily Ho; Roderick H Dashwood
Journal:  FASEB J       Date:  2006-01-11       Impact factor: 5.191

5.  Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation.

Authors:  Paul Talalay; Jed W Fahey; Zachary R Healy; Scott L Wehage; Andrea L Benedict; Christine Min; Albena T Dinkova-Kostova
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-23       Impact factor: 11.205

6.  Sulforaphane suppresses ultraviolet B-induced inflammation in HaCaT keratinocytes and HR-1 hairless mice.

Authors:  Akira Shibata; Kiyotaka Nakagawa; Hiroko Yamanoi; Tsuyoshi Tsuduki; Phumon Sookwong; Ohki Higuchi; Fumiko Kimura; Teruo Miyazawa
Journal:  J Nutr Biochem       Date:  2009-07-02       Impact factor: 6.048

7.  HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates.

Authors:  Praveen Rajendran; Ariam I Kidane; Tian-Wei Yu; Wan-Mohaiza Dashwood; William H Bisson; Christiane V Löhr; Emily Ho; David E Williams; Roderick H Dashwood
Journal:  Epigenetics       Date:  2013-04-26       Impact factor: 4.528

8.  Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells.

Authors:  Shivendra V Singh; Renaud Warin; Dong Xiao; Anna A Powolny; Silvia D Stan; Julie A Arlotti; Yan Zeng; Eun-Ryeong Hahm; Stanley W Marynowski; Ajay Bommareddy; Dhimant Desai; Shantu Amin; Robert A Parise; Jan H Beumer; William H Chambers
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

9.  Stabilization of quercetin paradoxically reduces its proapoptotic effect on UVB-irradiated human keratinocytes.

Authors:  Erik R Olson; Tania Melton; Zigang Dong; G Tim Bowden
Journal:  Cancer Prev Res (Phila)       Date:  2008-10

10.  Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6.

Authors:  Angela Gibbs; Jacob Schwartzman; Vivianne Deng; Joshi Alumkal
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-15       Impact factor: 11.205

View more
  5 in total

Review 1.  Research progress on chemopreventive effects of phytochemicals on colorectal cancer and their mechanisms.

Authors:  Teng-Fei Yin; Min Wang; Ying Qing; Ying-Min Lin; Dong Wu
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

Review 2.  Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors.

Authors:  Eunah Kim; William H Bisson; Christiane V Löhr; David E Williams; Emily Ho; Roderick H Dashwood; Praveen Rajendran
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

3.  Epigenetic modifications of triterpenoid ursolic acid in activating Nrf2 and blocking cellular transformation of mouse epidermal cells.

Authors:  Hyuck Kim; Christina N Ramirez; Zheng-Yuan Su; Ah-Ng Tony Kong
Journal:  J Nutr Biochem       Date:  2015-09-28       Impact factor: 6.048

4.  Reversible Keap1 inhibitors are preferential pharmacological tools to modulate cellular mitophagy.

Authors:  Nikolaos D Georgakopoulos; Michele Frison; Maria Soledad Alvarez; Hélène Bertrand; Geoff Wells; Michelangelo Campanella
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

Review 5.  Roles of Histone Acetylation Modifiers and Other Epigenetic Regulators in Vascular Calcification.

Authors:  Duk-Hwa Kwon; Juhee Ryu; Young-Kook Kim; Hyun Kook
Journal:  Int J Mol Sci       Date:  2020-05-04       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.